TABLE 2.
Study | Therapeutic regiment |
Cells |
Outcomes |
|||||||
Transducer | Parameters | Application | Duration | Length | Cell culture | Number | Proliferation | Apoptosis | Gene regulation | |
Zhang et al., 2009 | Bottom of the plate | 100 mW/cm2, 1 Mhz, 20% pulsed | Every day | 5 min | 14 days | Primary rat SC | 3.000/cm2 | Increased at day 4, 7 and 10 | n.d. | Increased NT3 expression and decreased BDNF expression at day 14 (RT-PCR) |
Tsuang et al., 2011 | Immersed | 300 mW/cm2, 1 Mhz, 20% pulsed | Once | 2 min | 2 days | Primary rat SC | 2.000/cm2 | Increased at day 2 | Decreased at day 1 | n.d. |
Yue et al., 2016 | Bottom of the plate | 20 mW/cm2, 1 Mhz, 20% pulsed | Every day | 10 min | 7 days | Rat SC RSC96 | 60.000/cm2 | n.d. | n.d. | Increased ErbB3, NRG1, EGR2 and MBP expression at day 1, 4 and 7 (qPCR) |
Ren et al., 2018 | Bottom of the plate | 27.500 mW/cm2† | Every day | 10 min | 5 days | primary rat SC | 2.000/cm2 | Increased at day 5 | n.d. | Increased FDF, NGF, BDNF, GDNF, p-GSK-3β, β-catenin expression at day 5 (WB) |
Listed are the key elements of all analyzed studies including therapeutic regimen, cell type and number and major outcomes on Schwann cell proliferation, apoptosis, and gene expression. †, Ren et al. (2018) reported using an intensity of 27.5 W/cm2, which is considered high intensity ultrasound. For this table, we use the PRISMA 2020 guidelines for systematic review (Page et al., 2021) and identified 4 reports. SC, Schwann cell. n.d., not determined. qPCR, quantitative PCR. RT-PCR, reverse transcriptase PCR. WB, western blot.